Print
Email
The field of gene editing continues to witness remarkable advancements, with scientists pushing the boundaries of what can be achieved using CRISPR technology. BioIntel360 delves into several groundbreaking insights that highlight the potential of CRISPR-based gene editing systems, offering new avenues for precise and efficient genome modifications.
Scientists at Metagenomi, California, have characterized three novel CRISPR effector nucleases that outperform the well-known Cas9 system.
The type II (MG3-6 and MG3-6/4) and type V (MG29-1) of these novel systems, respectively derived from the human microbiome and a hydrothermal vent,
The researchers found that all three systems consistently achieved high-frequency gene editing with remarkable reproducibility. They successfully disrupted multiple target genes, such as T cell receptor (TCR) alpha- and beta-chains, β2-microglobulin, TIGIT, FAS, and PDCD1, demonstrating the potential of these systems for precise gene modifications.
Overcoming the challenges of CRISPR-based mitochondrial DNA (mtDNA) editing, a new TALEN-based method has emerged as an efficient approach. Circular RNAs encoding the mitoBEs (mitochondrial base editors) were introduced into patient-derived cells, and this procedure increased base-editing efficiency by up to 77%. The high specificity and strand-selective base editing capabilities of this method make it a promising tool for addressing pathogenic mtDNA mutations, which were previously difficult to modify.
In an exciting development, American scientists have demonstrated the CRISPR-based engineering of RNA viruses. Precise deletions and insertions in RNA sequences were achieved by combining sequence-specific VRISPR-based RNA cleavage with programmed RNA repair. Remarkably, approximately 5% of the bulk virus was edited as intended, offering potential applications in understanding viral biology and developing targeted antiviral strategies.
In-frame deletion, homology-directed repair (HDR), and prime editing (PE) are three gene editing strategies that have been used to cure DMD mutations. Danish and Chinese researchers conducted a comparison study to assess the effectiveness of these three approaches. In HEK293T cells, the study found that HDR (21–24%) and PE2 (1.5%) had the lowest editing effectiveness, while non-homologous blunt end joining (NHBEJ) had the highest (74–77%).
These findings provide valuable insights into the most effective gene editing strategies for DMD correction.
A new technique known as LOCK (Large DNA fragments through OdsDNA with Conjugation and Knock-in) has emerged as a versatile and efficient method for integrating large DNA fragments into mammalian genomes. LOCK accomplished exceptionally effective targeted insertion of gene-sized DNA pieces with minimal off-target consequences by utilising specially created 3'-overhang double-stranded DNA (odsDNA) donors with 50-nt homology arms. The knock-in frequencies achieved were over fivefold higher compared to conventional homologous recombination-based approaches, offering a cost-effective and precise method for large-scale DNA integration.
BioIntel360 suggests that the advancements and breakthroughs in gene editing using CRISPR technology continue to revolutionize the field of genetic research. The studies highlighted here demonstrate the remarkable potential of CRISPR-based systems for precise and efficient genome modifications.
